[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352917-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352917-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","leveraging-ai-chatbots-in-supporting-breast-and-ovarian-cancer-patients-a-scoping-review","Leveraging AI chatbots in supporting breast and ovarian cancer patients - A scoping review","","Objective: People at risk of, or diagnosed with, breast and ovarian cancer face barriers to timely help, including embarrassment, complex information needs, and limited access to support. This scoping review systematically examines chatbot uses in care, emphasizing design, functionalities, evaluation outcomes, and implementation barriers and facilitators. Methods: Searches across major biomedical databases applied PRISMA-ScR screening. Results: Nineteen studies covered education, clinical, and psychosocial support; NLP dominated, satisfaction was high, while RCT clinical efficacy was mixed. Conclusions: Chatbots may complement care; future work should standardize evaluation frameworks, expand ovarian cancer research, and optimize automation with human oversight.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/leveraging-ai-chatbots-in-supporting-breast-and-ovarian-cancer-patients-a-scoping-review/352917/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/leveraging-ai-chatbots-in-supporting-breast-and-ovarian-cancer-patients-a-scoping-review/352917.png","ImageObject",300,407,{"name":42,"@type":43},"Chumphorn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",17,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What barriers to support do breast and ovarian cancer patients commonly face?","Question",{"text":63,"@type":64},"Barriers include embarrassment, complex information needs, and limited access to timely, reliable support resources.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the review evaluate chatbot research in breast and ovarian cancer care?",{"text":68,"@type":64},"It used a comprehensive search of PubMed, Medline, Embase, CINAHL, Cochrane Library, and Web of Science, screening studies according to PRISMA-ScR guidelines.",{"name":70,"@type":61,"acceptedAnswer":71},"What technical approaches and outcomes were reported for chatbots in the included studies?",{"text":72,"@type":64},"NLP was the primary technical foundation, with rule-based and retrieval-based approaches and an increasing use of LLM-driven methods; user satisfaction was consistently high, while RCT evidence on clinical efficacy showed mixed results across patient subgroups.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352917,1790130897,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","Leveraging AI chatbots in supporting breast and ovarian cancer patients: A scoping review  \nVivian Hui1,2, Lidan Tian1 , Xinyu Feng1 , Xiaoling Yuan3, Janelle Yorke1,4, and Young Ji Lee2,5  \nDIGITAL HEALTH Volume 12: 1–19 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)  \n[DOI: 10.1177/20552076261451390](DOI: 10.1177/20552076261451390)  \n[journals.sagepub.com/home/dhj](journals.sagepub.com/home/dhj)  \nAbstract  \nObjective: Individuals who are at risk of or diagnosed with breast and ovarian cancer often face barriers in seeking help due to embarrassment, complex information needs, and limited access to timely support. Chatbots provide a private, nonjudgmental communication interface that may help overcome these barriers. This scoping review systematically examines chatbot applications in breast and ovarian cancer care, focusing on their design, functionalities, evaluation outcomes, and implementation barriers and facilitators. Methods: A comprehensive search was conducted through PubMed, Medline, Embase, CINAHL, Cochrane Library, and Web of Science databases using keywords related to chatbots, breast cancer, and ovarian cancer. Studies were screened and reviewed following PRISMA-ScR guidelines. Results: Nineteen studies met the inclusion criteria, covering educational support (n=16), clinical support (n=14), and psychosocial support (n=11) . NLP served as the primary technical foundation (n=12), with rule-based and retrieval-based approaches equally represented (n=7 each) and a growing adoption of LLM-driven approaches (n=5) . Studies reported consistently high user satisfaction, though RCT evidence on clinical efficacy showed mixed results with benefits varying by patient subgroups. Qualitative studies identified adoption barriers including data privacy concerns and patient expectations exceeding chatbot scope. While breast cancer applications showed promising outcomes, research on diagnosed ovarian cancer patients remains limited. Conclusions: Chatbots show potential as complementary tools in breast and ovarian cancer care. Future development should focus on standardised evaluation frameworks, specialized ovarian cancer applications, and optimizing the balance between automation and human oversight in clinical settings.  \nKeywords  \nAI chatbots, large language models, patient education, breast cancer, ovarian cancer, generative AI Received: 28 October 2025; Revised: 15 April 2026; Accepted: 25 April 2026  \nIntroduction  \nBreast and ovarian cancers are major malignancies with profound impacts on global health that are frequently studied together due to their shared risk factors and similar treatment approaches. According to the World Health Organization,1 breast cancer ranks as the most prevalent cancer among females in 157 out of 185 countries, with an annual incidence of  \n1School of Nursing, The Hong Kong Polytechnic University, Hong Kong, Hong Kong SAR  \n2Department of Health and Community Systems, School of Nursing, University of Pittsburgh, Pittsburgh, USA 3School of Nursing, Shanghai Jiao Tong University, Shanghai, China  \n4Division of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK 5Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, USA  \nCorresponding author:  \nVivian Hui, School of Nursing, The Hong Kong Polytechnic University, HJ 544, Hung Hom, Kowloon, Hong Kong SAR. Email: [vivianc.hui@polyu.edu.hk](vivianc.hui@polyu.edu.hk)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/na","cbCaisUlDNV3fxyJ","https://ap.wps.com/l/cbCaisUlDNV3fxyJ","pdf",4121782,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What barriers to support do breast and ovarian cancer patients commonly face?\",\"answer\":\"Barriers include embarrassment, complex information needs, and limited access to timely, reliable support resources.\"},{\"question\":\"How did the review evaluate chatbot research in breast and ovarian cancer care?\",\"answer\":\"It used a comprehensive search of PubMed, Medline, Embase, CINAHL, Cochrane Library, and Web of Science, screening studies according to PRISMA-ScR guidelines.\"},{\"question\":\"What technical approaches and outcomes were reported for chatbots in the included studies?\",\"answer\":\"NLP was the primary technical foundation, with rule-based and retrieval-based approaches and an increasing use of LLM-driven methods; user satisfaction was consistently high, while RCT evidence on clinical efficacy showed mixed results across patient subgroups.\"}]","Leveraging AI chatbots in supporting breast and ovarian cancer patients - A scoping review | PDF",1790101977,48,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b40eb7f37965b0b121ce0929181209a.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8a67bd510b0f0eb526749a207e30abc.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbec4e4a1b82ae39f3c82e3bd495c338.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4591d58c22d88f97f2b596a67e6617ad.webp",980,1306]